IMPAX Laboratories, Inc. (IPXL) Drives Stronger Performance with IBM Business Analytics
11/20/2009 10:02:46 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) to Present at the Credit Suisse 18th Annual Healthcare Conference
11/11/2009 10:23:31 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) Continues Trend of Solid Growth in Revenue, Profit and Earnings for the Third Quarter 2009
11/3/2009 9:15:08 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) Confirms Patent Challenge Relating to TRICOR(R) 48mg and 145mg Tablets
10/30/2009 9:32:32 AM
More...
|
Japan's Astellas Pharma Inc. (JOBS) Settles with IMPAX Laboratories, Inc. (IPXL) on Prostate Drug
10/7/2009 4:45:32 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) Receives Tentative FDA Approval for Generic FLOMAX(R) 0.4mg Capsules
10/5/2009 9:52:23 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) Commences Shipment of Generic Adderall XR(R) Capsules, 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg
10/2/2009 8:39:25 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) to Present at the JMP Securities Healthcare Focus Conference
9/29/2009 10:09:10 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) Confirms Patent Challenge Relating to ORACEA(R) Delayed-Release Capsules, 40mg
9/21/2009 9:36:02 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) to Present at the UBS Global Life Sciences Conference
9/16/2009 1:11:44 PM
More...
|
|